Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Zivo Bioscience's share price for the quarter that ended in Dec. 2023 was $1.2. Zivo Bioscience's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 2.38 Mil. Therefore, Zivo Bioscience's market cap for the quarter that ended in Dec. 2023 was $2.86 Mil.
Zivo Bioscience's quarterly market cap
declined
from Jun. 2023 ($22.80 Mil) to Sep. 2023 ($13.58 Mil) and
declined
from Sep. 2023 ($13.58 Mil) to Dec. 2023 ($2.86 Mil).
Zivo Bioscience's annual market cap
declined
from Dec. 2021 ($27.03 Mil) to Dec. 2022 ($23.55 Mil) and
declined
from Dec. 2022 ($23.55 Mil) to Dec. 2023 ($2.86 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zivo Bioscience's Enterprise Value for Today is $18.27 Mil.
Zivo Bioscience Market Cap Historical Data
The historical data trend for Zivo Bioscience's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zivo Bioscience's Market Cap
For the Biotechnology subindustry, Zivo Bioscience's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zivo Bioscience's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zivo Bioscience's Market Cap distribution charts can be found below:
* The bar in red indicates where Zivo Bioscience's Market Cap falls into.
Zivo Bioscience Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Zivo Bioscience's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zivo Bioscience (OTCPK:ZIVO) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Zivo Bioscience Market Cap Related Terms
Thank you for viewing the detailed overview of Zivo Bioscience's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Zivo Bioscience (Zivo Bioscience) Business Description
Zivo Bioscience Inc is a research and development company operating in both the biotech and agtech sectors, with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's pipeline candidates are; Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Human Food Ingredients, and Skin Health.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZIVO has been successfully added to your 